Pharma Journalist -

The European Commission (EC) approved a new indication for Dupixent (dupilumab) in chronic rhinosinusitis with nasal polyposis (CRSwNP). Dupixent is indicated as an add-on therapy with…
Read More...

During the 2019 edition of the PREDiCT: 3D Tissue Models Summit, we caught up with StemoniX ahead of their presentation to gain insight on their current work and future projects!…
Read More...

Enesi Pharma, the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce that it has been awarded grant funding…
Read More...

SMi has released an exclusive interview with industry expert Che Connon, Professor of Tissue Engineering at Newcastle University, ahead of the upcoming Ophthalmic Drugs conference which…
Read More...

SMi Reports: A Focus Day has been added to SMi’s RNA Therapeutics Conference, which will highlight the recent developments in "Oligonucleotide Delivery Systems." SMi Group are proud to…
Read More...

Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the US and Canada, and Pfizer Inc. announced that the European Commission (EC) has…
Read More...

GlaxoSmithKline plc announced that patient dosing has begun in a phase III clinical programme investigating gepotidacin, the first in a new chemical class of antibiotics called…
Read More...

Ziopharm Oncology and The University of Texas MD Anderson Cancer Center announced a new research and development agreement relating to Ziopharm’s Sleeping Beauty immunotherapy program…
Read More...

CARsgen Therapeutics Co. Ltd., a clinical-stage biopharmaceutical company announced that the United States Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced…
Read More...

Gilead Sciences Inc. and Glympse Bio, Inc., announced that the companies have entered into a strategic collaboration in nonalcoholic steatohepatitis (NASH) clinical development. Glympse…
Read More...